Lv5
1468 积分 2025-09-11 加入
Has the Introduction of PARP Inhibitors Alleviated the Global, Regional and National Burden of Ovarian Cancer? A Segmented Regression Analysis of the Global Burden of Disease Study, 2007-2021
1个月前
已完结
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer
2个月前
已完结
Serotonin-licensed macrophages potentiate chemoresistance via inositol metabolic crosstalk in ovarian cancer
3个月前
已完结
Curcuminoids WM03 inhibits ovarian cancer cisplatin-resistant cells proliferation and reverses cisplatin resistance by targeting DYRK2
3个月前
已完结
Novel quinoline-4-carboxamide derivatives potentiates apoptosis by targeting PDK1 to overcome chemo-resistance in colorectal cancer: Theoretical and experimental results
3个月前
已完结
Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe2+ accumulation
3个月前
已完结
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome
3个月前
已完结
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer
3个月前
已完结
Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi‐omics study integrating machine learning, mendelian randomization and mediation analysis
4个月前
已完结
Astragaloside II enhanced sensitivity of ovarian cancer cells to cisplatin via triggering apoptosis and autophagy
4个月前
已完结
皖公网安备34019202002308
